Categories : Oncology
Product Packaging : 1 Vial
Product Composition : 150 mg
Fosaprepitant Dimeglumine for Injection is a neurokinin-1 (NK1) receptor antagonist used for the prevention of chemotherapy-induced nausea and vomiting (CINV). It works by blocking substance P/neurokinin signals in the central nervous system, helping to effectively control delayed and acute nausea associated with cancer chemotherapy.
This injectable formulation is commonly used as part of combination antiemetic therapy alongside 5-HT3 antagonists and corticosteroids in oncology settings.
Genliva Wellness LLP is a trusted Fosaprepitant Dimeglumine Injection exporter in India, offering high-quality antiemetic oncology support products for global markets. As a reliable Fosaprepitant injection contract manufacturer and third party manufacturer, the company supports hospitals, oncology centers, and pharmaceutical distributors worldwide.
Send MessageFosaprepitant Dimeglumine for Injection is a neurokinin-1 (NK1) receptor antagonist used for the prevention of chemotherapy-induced nausea and vomiting (CINV). It works by blocking substance P/neurokinin signals in the central nervous system, helping to effectively control delayed and acute nausea associated with cancer chemotherapy.
This injectable formulation is commonly used as part of combination antiemetic therapy alongside 5-HT3 antagonists and corticosteroids in oncology settings.
Genliva Wellness LLP is a trusted Fosaprepitant Dimeglumine Injection exporter in India, offering high-quality antiemetic oncology support products for global markets. As a reliable Fosaprepitant injection contract manufacturer and third party manufacturer, the company supports hospitals, oncology centers, and pharmaceutical distributors worldwide.
Fosaprepitant Dimeglumine for Injection is indicated for:
